Biocept, Inc. (BIOCQ)

USD 0.0

(0.0%)

Net Income Summary of Biocept, Inc.

  • Biocept, Inc.'s latest annual net income in 2022 was -32.08 Million USD , down -1036.23% from previous year.
  • Biocept, Inc.'s latest quarterly net income in 2023 Q2 was -3.63 Million USD , up 49.17% from previous quarter.
  • Biocept, Inc. reported an annual net income of -2.82 Million USD in 2021, up 84.14% from previous year.
  • Biocept, Inc. reported an annual net income of -17.8 Million USD in 2020, up 29.16% from previous year.
  • Biocept, Inc. reported a quarterly net income of -3.63 Million USD for 2023 Q2, up 49.17% from previous quarter.
  • Biocept, Inc. reported a quarterly net income of -18.52 Million USD for 2022 Q4, down -82.93% from previous quarter.

Annual Net Income Chart of Biocept, Inc. (2022 - 2019)

Historical Annual Net Income of Biocept, Inc. (2022 - 2019)

Year Net Income Net Income Growth
2022 -32.08 Million USD -1036.23%
2021 -2.82 Million USD 84.14%
2020 -17.8 Million USD 29.16%
2019 -25.13 Million USD 0.0%

Peer Net Income Comparison of Biocept, Inc.

Name Net Income Net Income Difference
American Bio Medica Corporation -1.41 Million USD -2175.674%
Arrayit Corporation -3.31 Million USD -867.76%
Atlantic International Corp. -5.62 Million USD -470.173%
Bioqual, Inc. 483.48 Thousand USD 6736.662%
CardioGenics Holdings Inc -1.91 Million USD -1574.404%
DermTech, Inc. -100.88 Million USD 68.195%
Global WholeHealth Partners Corporation - USD Infinity%
Hangzhou Tigermed Consulting Co., Ltd. 2.02 Billion USD 101.585%
HTG Molecular Diagnostics, Inc. -21.59 Million USD -48.589%
iMD Companies, Inc. -200.63 Thousand USD -15892.643%
IDenta Corp. 14.64 Thousand USD 219213.63%
Interpace Biosciences, Inc. 802 Thousand USD 4100.873%
Integrative Health Technologies, Inc. 38.68 Thousand USD 83035.718%
InVitro International 1553.00 USD 2066230.071%
Lumos Diagnostics Holdings Limited -8.59 Million USD -273.452%
Many Bright Ideas Technologies Inc. -58.11 Thousand USD -55115.79%
Medical Imaging Corp. -3.02 Million USD -961.421%
NovelStem International Corp. -4.18 Million USD -666.293%
Optigenex Inc. -2.89 Million USD -1007.304%
PharmChem, Inc. 845.1 Thousand USD 3896.82%
Proteome Sciences plc -2.44 Million USD -1213.426%
Response Genetics, Inc -20.18 Million USD -58.972%
Rennova Health, Inc. -3.29 Million USD -874.384%
RushNet, Inc. -607.02 Thousand USD -5185.918%
ScreenPro Security Inc. -2.24 Million USD -1326.871%
Stella Diagnostics Inc. -5.7 Million USD -462.197%
StageZero Life Sciences Ltd. -11.41 Million USD -181.086%
Todos Medical Ltd. -24.99 Million USD -28.379%